<VariationArchive VariationID="2501708" VariationName="NM_004797.4(ADIPOQ):c.276_285del (p.Gly93fs)" VariationType="Deletion" Accession="VCV002501708" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-05-13" MostRecentSubmission="2023-05-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2524647" VariationID="2501708">
      <GeneList>
        <Gene Symbol="ADIPOQ" FullName="adiponectin, C1Q and collagen domain containing" GeneID="9370" HGNC_ID="HGNC:13633" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q27.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="186842710" stop="186858463" display_start="186842710" display_stop="186858463" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="186560462" stop="186576251" display_start="186560462" display_stop="186576251" Strand="+" />
          </Location>
          <OMIM>605441</OMIM>
        </Gene>
        <Gene Symbol="ADIPOQ-AS1" FullName="ADIPOQ antisense RNA 1" GeneID="100874095" HGNC_ID="HGNC:40648" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q27.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="186851886" stop="186861368" display_start="186851886" display_stop="186861368" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_004797.4(ADIPOQ):c.276_285del (p.Gly93fs)</Name>
      <CanonicalSPDI>NC_000003.12:186854241:CCGAGGCTTTCCG:CCG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q27.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="186854242" stop="186854251" display_start="186854242" display_stop="186854251" variantLength="10" positionVCF="186854241" referenceAlleleVCF="CCCGAGGCTTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="186572031" stop="186572040" display_start="186572031" display_stop="186572040" variantLength="10" positionVCF="186572030" referenceAlleleVCF="CCCGAGGCTTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G93fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.186572034_186572043del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.186572034_186572043del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.186854245_186854254del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.186854245_186854254del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021140.1" sequenceAccession="NG_021140" sequenceVersion="1" change="g.16572_16581del">
            <Expression>NG_021140.1:g.16572_16581del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046662.2" sequenceAccession="NR_046662" sequenceVersion="2" change="n.2002_2011del">
            <Expression>NR_046662.2:n.2002_2011del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177800.2" sequenceAccession="NM_001177800" sequenceVersion="2" change="c.276_285del">
            <Expression>NM_001177800.2:c.276_285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171271.1" sequenceAccession="NP_001171271" sequenceVersion="1" change="p.Gly93fs">
            <Expression>NP_001171271.1:p.Gly93fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004797.4" sequenceAccession="NM_004797" sequenceVersion="4" change="c.276_285del" MANESelect="true">
            <Expression>NM_004797.4:c.276_285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004788.1" sequenceAccession="NP_004788" sequenceVersion="1" change="p.Gly93fs">
            <Expression>NP_004788.1:p.Gly93fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004797.4" sequenceAccession="NM_004797" sequenceVersion="4" change="c.273_282del" MANESelect="true">
            <Expression>NM_004797.4:c.273_282del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="605441.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004797.4(ADIPOQ):c.276_285del (p.Gly93fs) AND Adiponectin deficiency" Accession="RCV003228146" Version="8">
        <ClassifiedConditionList TraitSetID="6701">
          <ClassifiedCondition DB="MedGen" ID="C2675517">Adiponectin deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-05-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-05-13" MostRecentSubmission="2023-05-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">35869090</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6701" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Serum level of adiponectin 1</ElementValue>
                <XRef ID="Serum+level+of+adiponectin+1/9285" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Adiponectin deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADPOD</ElementValue>
                <XRef Type="MIM" ID="612556" DB="OMIM" />
              </Symbol>
              <XRef ID="C2675517" DB="MedGen" />
              <XRef Type="MIM" ID="612556" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7336086" SubmissionDate="2023-05-10" DateLastUpdated="2023-05-13" DateCreated="2023-05-13">
        <ClinVarSubmissionID localKey="605441.0002_ADIPONECTIN DEFICIENCY" title="ADIPOQ, 10-BP DEL, EXON 3_ADIPONECTIN DEFICIENCY" />
        <ClinVarAccession Accession="SCV003924088" DateUpdated="2023-05-13" DateCreated="2023-05-13" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with low plasma adiponectin, type 2 diabetes, and end-stage renal disease (ADPOD; 612556), Simeone et al. (2022) detected a heterozygous 10-nucleotide deletion (CCCGAGGCTTT-C) in exon 3 of the ADIPOQ gene, resulting in a frameshift and premature termination of the adiponectin protein. This generates a novel peptide that terminates 73 amino acids after the deletion. Carriers of the mutation had significantly reduced circulating adiponectin, less than 20% of the levels found in noncarriers (p less than 0.05). Fast protein liquid chromatography (FPLC) and Western blot analysis of mutant and wildtype adiponectin revealed lack of high molecular weight (HMW) adiponectin complexes in carriers of the mutation, whereas HMW adiponectin was the most abundant isoform in the noncarriers. Additionally, carriers of the mutation had on average a 35% increase in C16.0 ceramide levels compared to noncarriers (p less than 0.037). Functional studies demonstrated that wildtype adiponectin and the mutant variant interacted, leading to decreased stability of the wildtype adiponectin. Simeone et al. (2022) suggested that the mutated adiponectin protein acts as a dominant negative through its interaction with nonmutated adiponectin, decreasing circulating adiponectin, and correlating with metabolic disease.</Attribute>
              <Citation>
                <ID Source="PubMed">35869090</ID>
              </Citation>
              <XRef DB="OMIM" ID="612556" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADIPOQ" />
          </GeneList>
          <Name>ADIPOQ, 10-BP DEL, EXON 3</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">10-BP DEL, EXON 3</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605441.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADIPONECTIN DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7336086" TraitType="Disease" MappingType="Name" MappingValue="ADIPONECTIN DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C2675517" Name="Adiponectin deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

